Inadequate response to Ebola should not be repeated with Chikungunya -Sir Ron Sanders
The good news is that a prophylactic vaccine against chikungunya, developed by the Austrian biotech company Themis Bioscience GmbH, is reported to induce a significant neutralizing immune response to the disease and is confirmed as safe.…
Read More...
Read More...